, ,

Mestiza (Enzalutamide) 40mg

0.00$

+ Free Shipping

Mestiza 40mg contains Enzalutamide, an androgen receptor inhibitor used to treat certain types of advanced prostate cancer. It is commonly prescribed for metastatic castration-resistant prostate cancer and other advanced prostate cancer settings as advised by an oncologist. Enzalutamide works by blocking androgen receptor activity, helping slow the growth and spread of prostate cancer cells.

Field Details
Original Brand Xtandi
Generic Brand Mestiza 40mg
Generic Name Enzalutamide 40mg
Pack Size As available in market
Use / Indications Advanced Prostate Cancer, Metastatic Prostate Cancer, Castration-Resistant Prostate Cancer
Manufacturer As per local supplier information
Status Prescription Only Medicine
Guaranteed Safe Checkout

Introduction to Xtandi (Enzalutamide) 40mg

Xtandi (Enzalutamide) 40mg is a prescription medicine used in the treatment of certain types of prostate cancer, especially advanced or metastatic prostate cancer. This medicine belongs to a specialized group of anticancer drugs that work by blocking the action of male hormones that help prostate cancer cells grow.

Xtandi (Enzalutamide) 40mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Oral Cancer Therapies. It contains Enzalutamide, which works by inhibiting androgen receptor signaling and helping slow the growth and spread of prostate cancer cells.

In some markets, Mestiza 40mg is available as a local brand containing the same active ingredient Enzalutamide, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.

What Is Xtandi (Enzalutamide) 40mg?

Xtandi is the original brand name for Enzalutamide, an oral medication widely used for the treatment of prostate cancer.

Enzalutamide belongs to a class of medicines known as Androgen Receptor Inhibitors. These medicines help block the effects of androgens such as testosterone, which can stimulate the growth of prostate cancer cells.

Generic or local brands such as Mestiza 40mg contain the same active compound and may be used depending on physician recommendation and regional availability.

Drug Class and Mechanism of Action

Enzalutamide is classified as an androgen receptor inhibitor with strong antineoplastic properties.

How Enzalutamide Works

It works in several ways:

  • Blocks androgen receptors on prostate cancer cells
  • Prevents androgen-driven cancer cell growth signals
  • Inhibits cancer cell survival and proliferation
  • Helps slow disease progression in advanced prostate cancer

Through these mechanisms, Enzalutamide helps slow or stop the progression of certain prostate cancers.

How Xtandi Works in the Body

Prostate cancer cells often depend on androgen hormones for growth. Xtandi helps block these hormonal signals and interferes with the cancer’s ability to survive and spread.

Key Actions of Enzalutamide

  • Blocking androgen receptor activity
  • Preventing hormone-driven tumor growth
  • Slowing progression of metastatic prostate cancer
  • Supporting long-term disease control in selected patients

Some local brands such as Mestiza deliver the same active compound, allowing similar hormone-targeted cancer treatment when prescribed appropriately.

Medical Uses of Xtandi (Enzalutamide) 40mg

Xtandi 40mg is widely prescribed for several serious prostate cancer conditions.

Xtandi for Prostate Cancer

For patients with prostate cancer, Xtandi is commonly used as part of hormone-related anticancer therapy.

Potential Benefits

  • Delayed disease progression
  • Improved progression-free survival
  • Reduced cancer activity driven by androgens
  • Convenient oral treatment option

Local alternatives like Mestiza 40mg may also be used under medical supervision when Enzalutamide therapy is recommended.

Xtandi for Metastatic Castration-Resistant Prostate Cancer

Xtandi is particularly effective in patients with metastatic castration-resistant prostate cancer (mCRPC) and other advanced prostate cancer settings.

Treatment Benefits

  • Helps control advanced prostate cancer
  • Delays worsening of symptoms and disease spread
  • Supports better long-term treatment outcomes
  • Can be used in selected non-metastatic settings as prescribed

Who Can Take Mestiza 40mg?

Because Enzalutamide is a potent anticancer medicine, treatment should always be supervised by an experienced healthcare provider.

Eligibility Criteria

Patients may be prescribed Xtandi if they:

  • Are diagnosed with advanced or metastatic prostate cancer
  • Need androgen receptor-targeted therapy
  • Have been evaluated for seizure risk and other precautions
  • Can follow regular monitoring and treatment instructions

Certain local options such as Mestiza may also be considered depending on availability and physician decision.

Who Should Avoid Xtandi (Enzalutamide) 40mg

Xtandi should NOT be used by:

  • Individuals with hypersensitivity to Enzalutamide
  • Patients with certain seizure disorders unless carefully evaluated
  • Women who are pregnant or may become pregnant
  • Patients for whom androgen receptor inhibitor therapy is not appropriate

Xtandi (Enzalutamide) 40mg Dosage and Administration

Standard Dosage Guidelines

Typical dosage recommendations include:

  • Xtandi 40mg capsules or tablets as prescribed by the oncologist
  • Usually taken once daily in the total daily dose recommended by the doctor
  • Can be taken with or without food
  • Capsules or tablets should be swallowed whole

Dosage Adjustments

Doctors may adjust the dose depending on:

  • Individual treatment response
  • Side effects and tolerability
  • Liver function
  • Drug interactions with other medicines

Side Effects of Xtandi 40mg

Like all cancer medicines, Xtandi may cause side effects.

Common Side Effects

  • Fatigue and weakness
  • Hot flashes
  • Back pain
  • Decreased appetite
  • High blood pressure
  • Dizziness

Serious Side Effects

  • Seizures: Rare but important risk in susceptible patients
  • Falls and Fractures: Increased risk in some individuals
  • Hypertension: Significant blood pressure elevation
  • Severe Allergic Reactions: Rash, swelling, or breathing difficulty

Patients should report any unusual symptoms to their doctor immediately.

Storage:
Store below 30°C in a cool, dry place, protected from moisture and direct sunlight. Keep the capsules or tablets in their original packaging and out of reach of children.

Frequently Asked Questions (FAQs)

1. Is Xtandi (Enzalutamide) 40mg safe for long-term use?

Some patients take this medicine for an extended period, provided they are monitored regularly by an oncologist.

2. Can Mestiza 40mg be taken with food?

Yes. Enzalutamide can usually be taken with or without food unless your doctor gives specific instructions.

3. Is Xtandi (Enzalutamide) 40mg chemotherapy?

No. Xtandi is not traditional chemotherapy. It is a hormone-targeted anticancer therapy that blocks androgen receptor signaling.

4. Do I need regular monitoring while taking this medicine?

Yes. Doctors may recommend regular follow-up, blood pressure checks, and assessment for side effects during treatment.

5. Can women take Mestiza 40mg?

This medicine is not intended for use in women, especially during pregnancy, because it may cause harm to the unborn baby.

6. Is Mestiza 40mg the same as Xtandi?

Mestiza 40mg contains Enzalutamide, the same active ingredient found in Xtandi. Generic or local branded versions may be available depending on the market.

7. Do I need a prescription to buy Mestiza (Enzalutamide) 40mg?

Yes. Mestiza 40mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.

Medical Disclaimer

Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Xtandi (Enzalutamide) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.

Let's chat